Edwards Lifesciences's top three insider shareholders as of May 30, 2026 are Michael A Mussallem (Chairman Ceo, 4.04Mn shares), Larry L Wood (Global President Tavr Surg, 206.90K shares), Jean-Luc M Lemercier (Cvp, Emeacla And Japac, 184.69K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Donald E Jr Bobo | Cvp,Strategy/Corp Development | 0 | 111,605 | 04 May, 2023 |
| Michael A Mussallem | Chairman Ceo | 0 | 4,038,377 | 06 Nov, 2023 |
| Huimin Wang | Cvp, Japan Intercontinental | 99,381 | 0 | 08 Jul, 2022 |
| Nicholas J Valeriani | - | 79,296 | 0 | 09 May, 2025 |
| Catherine M. Szyman | Cvp, Critical Care | 81,287 | 0 | 03 Sep, 2024 |
| Larry L Wood | Global President Tavr Surg | 206,900 | 0 | 18 Aug, 2025 |
| Scott B. Ullem | Cvp, Chief Financial Officer | 39,699 | 0 | 09 Apr, 2026 |
| Robert W.A. Sellers | Svp, Corporate Controller | 17,081 | 0 | 13 May, 2024 |
| Bernard J Zovighian | Ceo | 80,976 | 11,517 | 13 Feb, 2026 |
| Jean-Luc M Lemercier | Cvp, Emeacla And Japac | 184,686 | 0 | 08 Jul, 2024 |
| Daveen Chopra | Cvp, Tmtt Surgical | 32,201 | 0 | 11 Dec, 2025 |
| Ramona Sequeira | - | 11,686 | 0 | 09 May, 2025 |
| Wayne Markowitz | Cvp, Japac | 17,563 | 0 | 08 Dec, 2025 |
| Daniel J. Lippis | Cvp, Tavr | 33,934 | 0 | 06 Apr, 2026 |
| Leslie C. Davis | - | 6,583 | 0 | 09 May, 2025 |
| Andrew M. Dahl | Svp, Corporate Controller | 9,089 | 0 | 23 Feb, 2026 |
| Annette Bruls | Cvp, Emeacla | 14,171 | 0 | 11 Jul, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Apr, 2026 | Scott B. Ullem | Common Stock | A | 13,000 | $59.26 | 52,699 | D | M |
| 09 Apr, 2026 | Scott B. Ullem | Common Stock | D | 4,676 | $80.50 | 48,023 | D | S |
| 09 Apr, 2026 | Scott B. Ullem | Common Stock | D | 8,324 | $79.79 | 39,699 | D | S |
| 09 Apr, 2026 | Scott B. Ullem | Employee Stock Option (Right to Acquire) | D | 13,000 | $0.00 | 13,000 | D | M |
| 06 Apr, 2026 | Daniel J. Lippis | Common Stock | A | 1,019 | $59.26 | 34,953 | D | M |
| 06 Apr, 2026 | Daniel J. Lippis | Common Stock | D | 1,019 | $80.98 | 33,934 | D | S |
| 06 Apr, 2026 | Daniel J. Lippis | Employee Stock Option (Right to Acquire) | D | 1,019 | $0.00 | 2,038 | D | M |
| 02 Apr, 2026 | Donald E Jr Bobo | Common Stock | A | 22,680 | $59.26 | 43,946 | D | M |
| 02 Apr, 2026 | Donald E Jr Bobo | Common Stock | D | 4,676 | $80.59 | 39,270 | D | S |
| 02 Apr, 2026 | Donald E Jr Bobo | Common Stock | D | 18,004 | $80.05 | 21,266 | D | S |
| 02 Apr, 2026 | Donald E Jr Bobo | Employee Stock Option (Right to Acquire) | D | 22,680 | $0.00 | 0 | D | M |
| 02 Mar, 2026 | Donald E Jr Bobo | Common Stock | A | 11,340 | $59.26 | 32,606 | D | M |
| 02 Mar, 2026 | Donald E Jr Bobo | Common Stock | D | 11,340 | $85.93 | 21,266 | D | S |
| 02 Mar, 2026 | Donald E Jr Bobo | Employee Stock Option (Right to Acquire) | D | 11,340 | $0.00 | 22,680 | D | M |
| 25 Feb, 2026 | Donald E Jr Bobo | Common Stock | D | 24,000 | $83.84 | 21,266 | D | S |
| 22 Feb, 2026 | Andrew M. Dahl | Common Stock | D | 176 | $79.78 | 9,089 | D | F |
| 12 Feb, 2026 | Bernard J Zovighian | Common Stock | A | 25,350 | $59.26 | 106,326 | D | M |
| 12 Feb, 2026 | Bernard J Zovighian | Common Stock | A | 25,350 | $59.26 | 106,326 | D | M |
| 12 Feb, 2026 | Bernard J Zovighian | Common Stock | A | 25,350 | $59.26 | 106,326 | D | M |
| 12 Feb, 2026 | Bernard J Zovighian | Common Stock | D | 2,532 | $77.13 | 103,794 | D | S |